Ann: IHL Provides Shareholder Information Events for Redomiciling, page-329

First 329 Last

Share
Profile

Follow
ime003

1,205 Posts.

258

01/09/23

09:41

Post #: 69680868
Share

Originally posted by malkazoid: ↑

Hey @ime003 - I'm glad you raised the exclusivity issue as it is something I've been meaning to delve into, and I currently have some confusion surrounding it. It was my impression that the exclusivity period the FDA grants concerns the formulation used: in other words it is the period during which no other company can create a generic version of your drug. If that's the case, then it may not be relevant to different drug formulations approved for the same indication.

Like I said, I'm unsure of my understanding of this and would be grateful if you had any materials that shed further light on this.
In the absolute, I hope I'm right mostly because it would not serve the public to block all other therapies for an indication for 7 years, and it would probably have a chilling effect on biotech investment by raising the risk of funding drug candidate programs that, if they lose the race to approval against another company with a drug targeting the same indication, they get zero return for 7 years and probably zero return indefinitely since by the time the exclusivity period has lapsed, science has marched on and better solutions may well exist. With multiple drug formulations competing for the same indication and being allowed to market without restriction, if you lose the race to be first, second prize can still produce tidy profits... and returning to the consumer: the consumer has more than one option depending on their specific health situation and needs.

Thoughts and facts welcome from all directions!

Expand

You are far more informed than I Malk. I believe you are correct in the formulation information.
I may withdraw my post due to lack of clarity.

IHL Price at posting: 8.2¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Bitcoin investors need to know the risks

There are more pages in this discussion • 4 more messages in this thread...

First 329 Last

Add IHL (ASX) to my watchlist

Ann: IHL Provides Shareholder Information Events for Redomiciling, page-329

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Immutep reports strong response rate from immunotherapies treating carcinomas

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nimy to raise $1.21M to explore 'newsy' WA targets

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Bitcoin investors need to know the risks

Featured News